Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? a bayesian analysis

HIGHLIGHTS

  • who: Andre C., Kalil and Junfeng, Sun from the Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Assistant Professor, Department of Biostatistics have published the article: Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis, in the Journal: (JOURNAL) of May/28,/2008
  • what: Answer 2-If the authors aim for a RRR.15% the mild skeptic analysis shows that the current probability of reducing death by this clinical threshold is 88% for the Intensive Insulin 62-65% for the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?